Doubling the clot-busting window sees more patients make full recovery
The window for successfully administering thrombolysis to patients who have had an ischaemic stroke can be doubled from 4.5 to nine hours, a landmark Australian trial has shown.
This results in more patients making a full recovery with little or no neurological defects, say the researchers, who predict stroke management guidelines will change around the world.
The trial medical co-ordinator, Associate Professor Henry Ma, says the finding is “terrific” news for patients who have experienced a stroke in their sleep.
“These results shift the stroke paradigm from